InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

VERV stock results show that Verve Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

STER Stock Earnings: Sterling Check Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

STER stock results show that Sterling Check missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024

By InvestorPlace Earnings

PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024.

FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Load More